3D CRISPR screen in prostate cancer cells reveals PARP inhibitor sensitization through TBL1XR1-SMC3 interaction is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health
Grant: U19 GM61388, R01 GM28157, R01 GM125633
U.S. Department of Defense
Grant: W81XWH-20-1-0262-01
Center for Individualized Medicine, Mayo Clinic
Grant: MC1351
NIGMS NIH HHS
Grant: R01 GM028157
NIGMS NIH HHS
Grant: R01 GM125633
NIGMS NIH HHS
Grant: U19 GM061388
Keywords